Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07874139 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE

Study acronym: PRESIDE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This observational, multicentric prospective study aims to understand the prevalence and burden of antimicrobial resistance (AMR) in people with chronic lung diseases (CLD) across the globe, understanding also geographical variability and the risk factors for acquiring AMR. The primary objective is to understand the prevalence and burden of AMR in CLD both at a local and gloval level. Secondary objectives include: 1) understanding susceptibilities models of high priority pathogens in people with CLD; 2) understanding geographic variability in the prevalence of AMR in CLD; 3) analysing risk factors for AMR in CLD Participants will be recruited
Trial Details
NCT Number NCT07874139
Lead Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators: European Respiratory Society, Royal Brompton & Harefield NHS Foundation Trust, Imperial College London
Conditions
(from sponsor)		 Chronic Lung Diseases
Enrollment 683 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov